Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer

被引:67
|
作者
Diez, M
Torres, A
Maestro, ML
Ortega, MD
Gomez, A
Pollan, M
Lopez, JA
Picardo, A
Hernando, F
Balibrea, JL
机构
[1] UNIV MADRID, SAN CARLOS HOSP, MADRID 3, SPAIN
[2] INST SALUD CARLOS 3, NATL CTR EPIDEMIOL, CANC EPIDEMIOL UNIT, MADRID, SPAIN
关键词
carcinoembryonic antigen; CA125; squamous cell carcinoma antigen; lung cancer; prognostic factor; survival;
D O I
10.1038/bjc.1996.239
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Risk of death and risk of recurrence in 108 potentially curable non-small-cell lung cancer patients were analysed with respect to TNM stage, histological type and carcinoembryonic antigen (CEA), CA125 antigen and squamous cell carcinoma antigen (SCC) levels in serum and cytosol. CA125 and CEA levels were closely related to outcome figures. Multivariate analyses indicated that TNM stage and histological type had the best predictive power. but serum and cytosolic CA125 and serum CEA contained additional, independent prognostic information. Predictive information drawn from serum and cytosolic levels proved mutually complementary. We conclude that CA125 and CEA complement TNM classification and histological type for the purpose of quantifying risk of death or recurrence.
引用
收藏
页码:1248 / 1254
页数:7
相关论文
共 50 条
  • [21] The effect of afatinib on CEA, CA125, CY-FRA21-1 levels in EGFR mutant non-small cell lung cancer patients
    Yue, Wu
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S434 - S434
  • [22] Preoperative serum CA125 is an independent predictor for prognosis in operable patients with non-small cell lung cancer
    Ying, L.
    Wu, J.
    Zhang, D.
    Li, Z.
    Li, D.
    Pan, X.
    Lv, H.
    Feng, J.
    NEOPLASMA, 2015, 62 (04) : 602 - 609
  • [23] Characteristics of Non-Small Cell Lung Cancer with High Serum CEA Levels
    Hoshijima, K.
    Shiono, S.
    Suzuki, J.
    Watanabe, H.
    Abe, K.
    Yasuda, S.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S430 - S430
  • [24] Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence
    Lai, IR
    Lee, WJ
    Huang, MT
    Lin, HH
    HEPATO-GASTROENTEROLOGY, 2002, 49 (46) : 1157 - 1160
  • [25] Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death lung cancer in resectable non-small lung cancer
    Pollán, M
    Varela, G
    Torres, A
    de la Torre, M
    Ludeña, MD
    Ortega, MD
    Pac, J
    Freixenet, J
    Gómez, G
    Sebastián, F
    Díez, M
    Arrabal, R
    Canalís, E
    García-Tirado, J
    Arnedillo, A
    Rivas, JJ
    Minguella, J
    Gómez, A
    García, M
    Aragonés, N
    Pérez-Gómez, B
    López-Abente, G
    González-Sarmiento, R
    Rojas, JM
    INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (05) : 781 - 790
  • [26] Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer Reply
    Horita, Nobuyuki
    Fujiwara, Yu
    Heymach, John V.
    Harpole, David
    Reck, Martin
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (03): : 287 - 288
  • [27] Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer
    Bernstein, ED
    Herbert, SM
    Hanna, NH
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (03) : 291 - 301
  • [28] Appropriate surgical treatment of resectable non-small-cell lung cancer
    Korst, RJ
    Ginsberg, RJ
    WORLD JOURNAL OF SURGERY, 2001, 25 (02) : 184 - 188
  • [29] Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Cedres, Susana
    Nunez, Isaac
    Longo, Marina
    Martinez, Pablo
    Checa, Eva
    Torrejon, Davis
    Felip, Enriqueta
    CLINICAL LUNG CANCER, 2011, 12 (03) : 172 - 179
  • [30] Prognostic Impact of Serum CA125 Level in Patients with cN0 Non-Small Cell Lung Cancer
    Yazaki, Y.
    Ichinose, J.
    Kawahara, M.
    Yoshimine, S.
    Suzuki, A.
    Matsuura, Y.
    Nakao, M.
    Okumura, S.
    Mun, M.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S494 - S494